Staging of Breast Cancer with 18F-FDG PET and PET/CT

被引：0
|
作者：
Aukema, Tjeerd S. [1 ]
Rutgers, Emiel J. T. [2 ]
Vogel, Wouter V. [1 ]
Olmos, Renato A. Valdes [1 ]
机构：
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Nucl Med, NL-1066 CX Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Surg, NL-1066 CX Amsterdam, Netherlands
来源：
CURRENT MEDICAL IMAGING REVIEWS | 2009年 / 5卷 / 04期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; SENTINEL-NODE BIOPSY; BROWN ADIPOSE-TISSUE; FDG-PET; SUSPECTED RECURRENCE; COMPUTED-TOMOGRAPHY; INTEGRATED PET/CT; BONE METASTASES; FOLLOW-UP; USA-FAT;
D O I：
10.2174/157340509790112871
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) has been recognised as a sensitive tool for the staging of various malignancies, such as lung carcinoma, lymphoma, and esophageal cancer. Its role in staging process of breast cancer however is subject to discussion, mainly due to supposedly lower metabolic activity of the disease. In this article, we discuss the current literature on FDG PET/CT for the staging of breast cancer, including staging of the primary tumour and the axilla, and the detection of distant metastases both in primary and recurrent breast cancer. In addition, we will focus on several methodological aspects and acquisition protocols to optimize the imaging of breast cancer patients by FDG PET/CT.
引用
收藏
页码：203 / 209
页数：7
相关论文
共 50 条
  • [31] Added Benefits of 18F-FDG PET/CT in the Primary Staging and Management of Patients with Breast Cancer
    Gunalp, B.
    Ince, S.
    Karacalioglu, A. O.
    Ayan, A.
    Emer, O.
    Alagoz, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S565 - S565
  • [32] 18F-FDG PET/CT in Bladder Cancer
    Tagliabue, Luca
    Russo, Giovanna
    Lucignani, Giovanni
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) : E522 - E524
  • [33] 18F-FDG PET/CT in ovarian cancer
    Gregianin, M.
    Dalla Palma, M.
    Evangelista, L.
    Cervino, A. R.
    Saladini, G.
    Borgato, L.
    Nicoletto, M. O.
    Zagonel, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S120 - S120
  • [34] 18F-FDG PET/CT in Staging Patients with Locally Advanced or Inflammatory Breast Cancer: Comparison to Conventional Staging
    Groheux, David
    Giacchetti, Sylvie
    Delord, Marc
    Hindie, Elif
    Vercellino, Laetitia
    Cuvier, Caroline
    Toubert, Marie-Elisabeth
    Merlet, Pascal
    Hennequin, Christophe
    Espie, Marc
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (01) : 5 - 11
  • [35] 18F-FDG PET in Recurrent Breast Cancer
    Magagnoli, G.
    Nanni, C.
    Castellucci, P.
    Farsad, M.
    Giosa, F.
    Morelli, R.
    Paladini, G.
    Messinese, S.
    Franchi, R.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S159 - S159
  • [36] Comparison of 18F-FDG PET/CT and CT or MRI for the Preoperative Staging of Ovarian Cancer
    Jung, G.
    Lee, Y.
    Oh, S.
    Byun, J.
    Ryu, I
    Kim, S.
    Chung, S.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (05)
  • [37] The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas
    Arslan, Esra
    Aksoy, Tamer
    Dursun, Nevra
    Gursu, Riza Umar
    Sevinc, Mert Mahsuni
    Cermik, Tevfik Fikret
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2020, 31 (02): : 105 - 112
  • [38] Pretreatment 18F-FDG PET/CT Staging in Gynecologic Cancers
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (11) : 17N - 17N
  • [39] Urinary Bladder Leiomyosarcoma Staging With 18F-FDG PET/CT
    Makis, William
    Rakheja, Rajan
    Nahal, Ayoub
    Hickeson, Marc
    Lisbona, Robert
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (05) : E218 - E222
  • [40] Staging and Response of Sternal Histoplasmosis by 18F-FDG PET/CT
    Karunanithi, Sellam
    Kumar, Ganesh
    Sharma, S. K.
    Jain, Deepali
    Gupta, Aashish
    Kumar, Rakesh
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (03) : 231 - 233
12345